![](/img/cover-not-exists.png)
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy
Pruller, Johanna, Hofer, Isabella, Ganassi, Massimo, Heher, Philipp, Ma, Michelle T., Zammit, Peter S.Journal:
Cancer Gene Therapy
DOI:
10.1038/s41417-020-00251-y
Date:
November, 2020
File:
PDF, 260 KB
2020